Farallon Capital builds over 3% stake in Japan's Astellas, FT reports
12/02/2025 05:08
Feb 12 (Reuters) - Farallon Capital Management has built a stake of more than 3% in Japanese pharmaceutical company Astellas 4503.T , the Financial Times reported on Wednesday, citing people familiar with the matter. (Reporting by Nilutpal Timsina in Bengaluru; Editing by Savio D'Souza) ((Nilutpal.Timsina@thomsonreuters.com; +91 86382 04706;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn